<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> (LA) are acquired autoantibodies that can cause <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>LAs prolong <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent coagulation tests, acting as nonspecific inhibitors that are neutralized in the presence of excess <z:chebi fb="0" ids="16247">phospholipid</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is no gold standard test and the testing is influenced by a number of variables </plain></SENT>
<SENT sid="3" pm="."><plain>This article summarizes laboratory testing for LAs, with particular focus on technical issues and limitations of testing </plain></SENT>
<SENT sid="4" pm="."><plain>Am </plain></SENT>
<SENT sid="5" pm="."><plain>J </plain></SENT>
<SENT sid="6" pm="."><plain>Hematol </plain></SENT>
<SENT sid="7" pm="."><plain>2009 </plain></SENT>
<SENT sid="8" pm="."><plain>(c) 2009 Wiley-Liss, Inc </plain></SENT>
</text></document>